Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

OBJECTIVE: This study investigated the efficacy, safety, tolerability, and pharmacokinetics of a novel cholesterol absorption inhibitor, FM-VP4, comprising disodium ascorbyl sitostanol phosphate (DASP) and disodium ascorbyl campestanol phosphate (DACP). METHODS: In phase 1, 30 men received a single...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vissers, Maud N., Trip, Mieke D., Pritchard, P. Haydn, Tam, Patrick, Lukic, Tatjana, de Sain-van der Velden, Monique G., de Barse, Martina, Kastelein, John J. P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer-Verlag 2008
Témata:
Clinical Trial
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2426926/
https://ncbi.nlm.nih.gov/pubmed/18320185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-008-0462-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky